117 related articles for article (PubMed ID: 16032968)
1. Binding of propofol to human serum albumin.
Schywalsky M; Ihmsen H; Knoll R; Schwilden H
Arzneimittelforschung; 2005; 55(6):303-6. PubMed ID: 16032968
[TBL] [Abstract][Full Text] [Related]
2. Influence of propofol concentration in human plasma on free fraction of the drug.
Dawidowicz AL; Kalitynski R; Kobielski M; Pieniadz J
Chem Biol Interact; 2006 Feb; 159(2):149-55. PubMed ID: 16318847
[TBL] [Abstract][Full Text] [Related]
3. 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
de la Fuente L; Lukas JC; Vázquez JA; Jauregizar N; Calvo R; Suárez E
Eur J Clin Pharmacol; 2002 Dec; 58(9):615-9. PubMed ID: 12483454
[TBL] [Abstract][Full Text] [Related]
4. Propofol binding to human blood proteins.
Altmayer P; Büch U; Büch HP
Arzneimittelforschung; 1995 Oct; 45(10):1053-6. PubMed ID: 8595056
[TBL] [Abstract][Full Text] [Related]
5. Influence of intralipid on free propofol fraction assayed in human serum albumin solutions and human plasma.
Kalitynski R; Dawidowicz AL; Poszytek J
Acta Pharmacol Sin; 2006 Dec; 27(12):1637-41. PubMed ID: 17112420
[TBL] [Abstract][Full Text] [Related]
6. Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics.
Mazoit JX; Samii K
Br J Clin Pharmacol; 1999 Jan; 47(1):35-42. PubMed ID: 10073737
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between changes in estimated and measured blood concentrations of propofol and serum albumin concentration during propofol anesthesia: effects of intraoperative bleeding (a case report)].
Kurehara K; Takahashi M; Hamasaki T; Kitaguchi K; Furuya H
Masui; 2000 May; 49(5):544-7. PubMed ID: 10846389
[TBL] [Abstract][Full Text] [Related]
8. In vitro release of propofol and binding capacity with regard to plasma constituents.
Schicher M; Polsinger M; Hermetter A; Prassl R; Zimmer A
Eur J Pharm Biopharm; 2008 Nov; 70(3):882-8. PubMed ID: 18640268
[TBL] [Abstract][Full Text] [Related]
9. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
[TBL] [Abstract][Full Text] [Related]
10. HPLC investigation of free and bound propofol in human plasma and cerebrospinal fluid.
Dawidowicz AL; Kalityński R
Biomed Chromatogr; 2003 Oct; 17(7):447-52. PubMed ID: 14598328
[TBL] [Abstract][Full Text] [Related]
11. Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding.
Hiraoka H; Yamamoto K; Okano N; Morita T; Goto F; Horiuchi R
Clin Pharmacol Ther; 2004 Apr; 75(4):324-30. PubMed ID: 15060510
[TBL] [Abstract][Full Text] [Related]
12. [Characterization of propofol binding to plasma proteins and possible interactions].
Garrido MJ; Jiménez RM; Rodríguez-Sasiaín JM; Aguirre C; Aguilera L; Calvo R
Rev Esp Anestesiol Reanim; 1994; 41(6):308-12. PubMed ID: 7838996
[TBL] [Abstract][Full Text] [Related]
13. [Determination of propofol in human serum by improved reversed phase high-performance liquid chromatography with fluorescence detection].
Fan YY; Xu LX; Wen AD; Zhang H; Liu CR; Li W; Mei XP
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1510-2. PubMed ID: 17062366
[TBL] [Abstract][Full Text] [Related]
14. Chromatographic assay and pharmacokinetic studies of propofol in human serum.
Emara S; Saleh G; Fathy M; Bakr MA
Biomed Chromatogr; 1999 Jun; 13(4):299-303. PubMed ID: 10416064
[TBL] [Abstract][Full Text] [Related]
15. Prediction of unbound propofol concentrations in a diabetic population.
de la Fuente L; Lukas JC; Jauregizar N; Vázquez JA; Calvo R; Suárez E
Ther Drug Monit; 2002 Dec; 24(6):689-95. PubMed ID: 12451283
[TBL] [Abstract][Full Text] [Related]
16. Anomalous relationship between free drug fraction and its total concentration in drug-protein systems I. Investigation of propofol binding in model HSA solution.
Dawidowicz AL; Kobielski M; Pieniadz J
Eur J Pharm Sci; 2008 May; 34(1):30-6. PubMed ID: 18374549
[TBL] [Abstract][Full Text] [Related]
17. Imidazole binding to human serum albumin.
Rodrigo MC; Ceballos A; Mariño E; Cachaza JM; Domínguez-Gil A; Kuemmerle HP
Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):320-2. PubMed ID: 3410610
[TBL] [Abstract][Full Text] [Related]
18. Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis.
Costela JL; Jiménez R; Calvo R; Suárez E; Carlos R
Acta Anaesthesiol Scand; 1996 Jul; 40(6):741-5. PubMed ID: 8836272
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentration for optimal sedation and total body clearance of propofol in patients after esophagectomy.
Takizawa D; Sato E; Nishikawa K; Hinohara H; Hiraoka H; Saito S; Goto F; Kunimoto F
J Anesth; 2005; 19(1):88-90. PubMed ID: 15674525
[TBL] [Abstract][Full Text] [Related]
20. Effects of a perfluorochemical emulsion on L-tryptophan binding by human albumin.
Sathe RS; Parsons DL
Arch Int Pharmacodyn Ther; 1990; 304():34-43. PubMed ID: 2241417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
